SORIATANE
We will be changing our web hosting provider during the next few days.
During this time, the site may work slowly or be unavailable.
We apologize for the inconvenience and kindly ask you to be patient!
Identification of Soriatane
| No description |
Google image searchProduct monograph
Active ingredient
acitretin, 25 MG
DIN: 02070863
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: ALLERGAN INC
Date: 20-MAR-2020
ATC:
- D05 — ANTIPSORIATICS (ATC, ATC/DDD, )
- D05B — ANTIPSORIATICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- D05BB — Retinoids for treatment of psoriasis (ATC, ATC/DDD)
- D05BB02 — ACITRETIN (ATC/DDD)
Reference brand drug: Soriatane
